Reprint
Radiopharmaceuticals
Edited by
January 2024
376 pages
- ISBN978-3-03928-620-1 (Hardback)
- ISBN978-3-03928-619-5 (PDF)
This book is a reprint of the Special Issue Radiopharmaceuticals that was published in
Chemistry & Materials Science
Medicine & Pharmacology
Summary
The purpose of this Special Issue was to host research and review papers on Radiopharmaceuticals in line with the three previous Special Issues that I have Guest Edited for Molecules. This subject may vary from radioactive isotope production, the synthesis of precures, radioactive labeling reactions, to the purification of radiopharmaceuticals to quality control and regulatory efforts, which are required prior to using radiopharmaceuticals in humans. This Special Issue contains 17 original research papers, 1 communication, 5 reviews, and 1 editorial review all within the area of radiochemistry.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
fatty acid synthase; cancer metabolism; positron emission tomography; carbon-11; PCa; [68Ga]Ga-PSMA-11; [18F]PSMA-1007; PSMA; [68Ge]/[68Ga] generator; cyclotron RCY; RCP; technetium-99m labelled macroaggregated albumin [99mTc]Tc-MAA; European Pharmacopoeia; lung perfusion scintigraphy; quality control; EANM recommendation; prostate cancer; [177Lu]Lu-PSMA-I&T; IMPD; quality assurance; alpha particles; auger electron; beta particles; nanotargeted therapy; radioligand therapy; medical isotope production; accelerator; nuclear medicine; review; radionuclide; targeted therapy; radionuclide therapy; radioactivity; molecular radiotherapy; beta; alpha; auger; 212Pb; 203Pb; 208Tl; MC1R; dosimetry; absorbed dose; melanoma; radiofluorination; PET imaging; GABAA; radiochemistry; Flumazenil 1; benzodiazepine; stannyl; stannane; octreotide; AlF; neuroendocrine; PET; gallium-68; F-18; 18F; aluminium fluoride (Al-F); pamidronic acid; radiopharmaceuticals; radiochemistry; positron emission tomography; bone imaging; radiopharmaceuticals; microscale radiosynthesis; thin-layer chromatography; miniaturization; preparative TLC; gallium-68; liquid–liquid extraction; liquid target; arylamino phosphonate; cyclotron production of gallium-68; fructose; neuroinflammation; PET; fluorine-18; GLUT5; microglia; FDG; FDF; [99mTc]Tc-PSMA-I&S; automated preparation; technetium-99m; Carbon-11; positron emission tomography (PET); radiochemistry; radiotracer; first-in-human; molybdenum; dissolution thermodynamics and kinetics; hydrogen peroxide; neutron source; fusion; α-synuclein; fluorine-18; radiofluorination; 6-[18F]fluoropiperonal; [18F]anle138b; one-pot synthesis; [13N]Ammonia; cGMP production; semi-automated production system; PET imaging; isotope production; theranostic radionuclide; accelerator; lutetium; cancer treatment; medical isotope; [68Ga]Ga-EDTA; PET; renography; GMP-production; Kit; 68Ga-colloids; [177Lu]Lu-PSMA-I&T; radiolysis; radioligand therapy; upscaling; quality assurance; HPLC; UPLC-MS; [18F]Fluoromethyl-(1,2-2H4)choline; positron emission tomography; choline; cell membrane metabolism; in vivo; in vitro; dosimetry; metastatic castrate-resistant prostate cancer; n/a